Phase 3, Phase 4Not yet recruitingAge-related condition

iSGLT2 in permanent atrial fibrillation, heart failure with preserved ejection fraction and intermediate NT-proBNP values: randomized clinical trial (PROGLIAF)

Sponsor

Institut D Investigacio Sanitaria Pere Virgili (Academic or other)

Enrolment

125 planned

Conditions

Heart failure; Atrial Fibrillation; Heart failure with preserved ejection fraction; Atrial fibrillation

Ages

older adults

Registry

CTIS2026-525968-18-00

Full record on the EU Clinical Trials Information System